Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Columbia Financial, Inc. filings document material events for the holding company of Columbia Bank, including furnished earnings releases, Regulation FD presentation materials, governance updates and capital-structure disclosures. Recent 8-K filings record operating and financial results, executive appointments, officer-designation matters and board succession disclosures involving the company and its wholly owned bank subsidiary.
The filing record also covers shareholder voting matters, material agreements and corporate-governance items that relate to Columbia Financial’s public-company reporting obligations. These disclosures connect the company’s banking operations with formal records on financial performance, management responsibilities, board composition and securities-related actions.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported updated equity holdings and a small compensation-related stock award. He received an indirect grant of 32.8198 shares of Common Stock at $20.86 per share through the Columbia Bank Stock Based Deferral Plan, where phantom stock units will be settled in shares upon distribution.
The filing also lists multiple indirect holdings in stock awards, retirement and employee plans, plus 63,662 shares of Common Stock held directly. Klimowich continues to hold several blocks of stock options on Columbia Financial common stock with exercise prices between $15.60 and $18.28 per share and expirations from 2029 to 2036, many of which are fully vested or vest in scheduled annual installments.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported a routine compensation-related share award rather than a market trade. On June 26, 2026, 89.0552 shares of Common Stock, valued at $20.86 per share, were credited to his holdings through the Columbia Bank Stock-Based Deferral Plan as phantom stock units.
Following this acquisition, indirect holdings under the stock-based deferral plan totaled 69,601.9984 shares. The filing also lists Kemly’s existing direct ownership of 249,269 shares of Common Stock and several blocks of stock options with exercise prices between $15.60 and $18.28 per share that vest over future years.
Columbia Financial, Inc. director Daria Stacy-Walls reported routine equity-related compensation activity linked to the Columbia Bank Stock Based Deferral Plan. On June 26, 2026, 479.3864 phantom stock units of common stock at $20.86 per unit were acquired on a non-discretionary basis by the trustee of the Bank's rabbi trust under this non-qualified stock-based deferral plan.
These stock unit interests will be settled in shares of stock upon distribution to the reporting person and are reported as indirect ownership "By Stock-Based Deferral Plan," bringing her indirect holdings to 29,562.5746 shares. A separate holding line shows 11,255 directly held common shares, with no buy or sell transactions disclosed.
Columbia Financial, Inc. director Holland Noel R. reported a compensation-related acquisition of common stock through a stock-based deferral plan. On June 26, 2026, 14.3815 phantom stock units tied to Columbia Financial common stock were credited at $20.86 per share under the Columbia Bank Stock Based Deferral Plan, held indirectly through a rabbi trust on a non-discretionary basis.
After this grant, the deferral plan account held 10,071.3002 common stock units. The filing also shows other existing holdings of common stock held directly and through retirement and stock award accounts, plus fully vested stock options with an exercise price of $15.60 per share expiring on July 23, 2029.
Columbia Financial, Inc. director Jim Hobart Wainwright filed an initial Form 3 showing his ownership in the company’s common stock. He reports 3,207 shares held directly, 2,952 shares as stock awards under the 2019 Equity Incentive Plan that vest on March 12, 2027, and 1,995 shares held indirectly through an ESOP. This filing establishes his baseline stake as a new reporting insider.
Columbia Financial, Inc. held its annual shareholder meeting on June 25, 2026, where investors approved a Plan of Conversion and Reorganization and the Agreement and Plan of Merger with Northfield Bancorp, Inc. Shareholders also supported related governance provisions, director elections, auditor ratification, and executive compensation proposals.
Key items passed with large majorities, including the merger proposal and two informational charter provisions covering super-majority voting for certain amendments and limits on voting rights above 10% ownership. All three director nominees were elected, KPMG LLP was ratified as independent auditor for 2026, and stockholders backed both say-on-pay and holding an annual advisory vote on executive compensation.
Columbia Financial, Inc. director Daria Stacy-Walls reported a routine compensation-related equity award. She acquired 235.5072 common stock-equivalent units at $20.70 per share through the Columbia Bank Stock Based Deferral Plan, where phantom stock held in a rabbi trust will later be settled in actual shares.
Following this grant, she indirectly holds 29,083.1882 common stock-equivalent units in the deferral plan, directly owns 11,255 common shares, and indirectly holds 2,952 stock awards under the 2019 Equity Incentive Plan that vest on March 12, 2027.
Columbia Financial, Inc. senior executive John Klimowich reported an update to his holdings that includes a small stock-based award. On June 12, 2026, he acquired 33.0734 shares of Common Stock at $20.70 per share through a stock-based deferral plan, treated as compensation rather than a market purchase.
The award represents phantom stock purchased on a non-discretionary basis by a trustee under the Columbia Bank Stock Based Deferral Plan and will be settled in shares upon distribution. Following this transaction, his indirect deferral-plan balance is 9,179.7669 shares, and he also holds multiple stock option grants with exercise prices between $15.60 and $18.28, expiring between 2029 and 2036.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported a small compensation-related stock acquisition and updated his holdings. On June 12, 2026, he acquired 89.7434 shares of common stock at $20.70 per share through a stock-based deferral plan, increasing that indirect position to 69,512.9432 shares.
The filing also lists various indirect common stock holdings through stock awards, spouse, retirement and benefit plans, plus a direct common stock position of 249,269 shares. In addition, he holds several option grants on common stock with exercise prices between about $15.60 and $18.28, expiring from 2029 to 2036. No open-market buys or sells were reported.
Columbia Financial, Inc. director Noel R. Holland reported routine equity compensation activity and updated holdings. On June 12, 2026, 8.2329 shares of phantom common stock at $20.70 per share were credited to his account under a stock-based deferral plan, increasing this indirect position to 10,056.9187 stock unit interests.
He also reported indirect holdings of 2,952 shares as stock awards that vest on March 12, 2027, and 46,280 shares held through a SEP-IRA, plus 36,726 shares held directly. In addition, he holds fully vested stock options covering 83,294 shares of common stock at an exercise price of $15.60 per share, expiring on July 23, 2029.